Utg INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
UTG, Inc. reported the results of its Annual Meeting of Shareholders held on June 30, 2026, including the election of seven directors and advisory votes on executive compensation.
OTC.Pink
UTG Inc.'s Compensation Committee approved cash and stock bonuses totaling $940,000 and salary increases for its CEO, CFO, and two Vice Presidents based on 2025 operating results.
OTC.Pink
UTG Inc. announced the appointment of Peter Ochs and Charles Perry to its Board of Directors, following the departure of Howard Dayton who will assume Emeritus status.
OTC.Pink
UTG Inc. shareholders have approved the 2025 Stock Option Plan, enabling the company to grant option shares to attract and retain key personnel.
OTC.Pink
UTG, Inc. announced the results of its Annual Meeting of Shareholders held on June 27, 2025, where all seven director nominees were elected, a new stock option plan was approved, and executive compensation received advisory approval.
OTC.Pink
UTG INC's Compensation Committee approved bonuses and salary increases for key executives based on the company's 2024 operating results.
OTC.Pink
UTG Inc.'s Board of Directors has reactivated its stock repurchase program, adding $1 million in funding and implementing a Rule 10b5-1 trading plan.
OTC.Pink
UTG Inc. reports the resignation of director April Chapman, effective June 28, 2024, due to other commitments.
OTC.Pink
UTG Inc. held its annual shareholder meeting on June 28, 2024, where nine directors were elected and executive compensation was approved on an advisory basis.
OTC.Pink
UTG Inc. has approved bonuses for key executives and a salary increase for a Vice President based on the company's 2023 operating results.